Therefore, the goal of the current study was to investigate the correlation and agreement between 2DE-ST strain and CMR strain, and the association between early 2DE-ST strain measurements and subsequent CMR-derived LVEF in patients with HER2-positive breast cancer during trastuzumab treatment. Here, ERBB2 is linked to breast cancer.